Survival after cutaneous melanoma in kidney transplant recipients: A population-based matched cohort study

American Journal of Transplantation

Volumn 14, Issue 6, 2014, Pages 1368-1375

  Vajdic, C M ^a   Chong, A H ^b,c   Kelly, P J ^d   Meagher, N S ^a   Van Leeuwen, M T ^a   Grulich, A E ^e   Webster, A C ^d,f,g  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f QUEEN ELIZABETH HOSPITAL   (Australia)

^g WESTMEAD HOSPITAL   (Australia)

Author keywords

Cohort; histopathology; melanoma; prognosis; survival; transplant

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; CUTANEOUS MELANOMA; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; AUSTRALIA; EPIDEMIOLOGY; HEALTH SURVEY; KIDNEY TUMOR; MELANOMA; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SKIN NEOPLASMS; SURVIVAL RATE;

AUSTRALIA; COHORT STUDIES; HUMANS; KIDNEY NEOPLASMS; MELANOMA; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84901371355     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12716     Document Type: Article

References (31)

1. AIHW. Cancer in Australia: An overview, 2012. Canberra: Australian Institute of Health and Welfare, 2012.
2. AIHW. Cancer survival and prevalence in Australia: Period estimates from 1982 to 2010. Canberra: Australian Institute of Health and Welfare, 2012.
3. Verdecchia A, Guzzinati S, Francisci S, et al. Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 2009; 45: 1042-1066.
4. Dickson PV, Gershenwald JE., Staging and prognosis of cutaneous melanoma. Surg Oncol Clin N Am 2011; 20: 1-17.
5. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-6206.
6. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM., Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 2007; 370: 59-67. (Pubitemid 47017468)
7. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306: 1891-1901.
8. Greene MH, Young TI, Clark WH Jr., Malignant melanoma in renal-transplant recipients. Lancet 1981; 1: 1196-1199. (Pubitemid 11102743)
9. Vajdic CM, van Leeuwen MT, Webster AC, et al. Cutaneous melanoma is related to immune suppression in kidney transplant recipients. Cancer Epidemiol Biomarkers Prev 2009; 18: 2297-2303.
10. Leveque L, Dalac S, Dompmartin A, et al. Melanoma in organ transplant patients. Ann Dermatol Venereol 2000; 127: 160-165. (Pubitemid 30182845)
11. Le Mire L, Hollowood K, Gray D, Bordea C, Wojnarowska F., Melanomas in renal transplant recipients. Br J Dermatol 2006; 154: 472-477. (Pubitemid 43382655)
12. Brown VL, Matin RN, Cerio R, Leedham-Green ME, Proby CM, Harwood CA., Melanomas in renal transplant recipients: The London experience, and invitation to participate in a European study. Br J Dermatol 2007; 156: 165-167. (Pubitemid 44924163)
13. Dapprich DC, Weenig RH, Rohlinger AL, et al. Outcomes of melanoma in recipients of solid organ transplant. J Am Acad Dermatol 2008; 59: 405-417.
14. Matin RN, Mesher D, Proby CM, et al. Melanoma in organ transplant recipients: Clinicopathological features and outcome in 100 cases. Am J Transplant 2008; 8: 1891-1900.
15. Miao Y, Everly JJ, Gross TG, et al. De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation 2009; 87: 1347-1359.
16. Brewer JD, Christenson LJ, Weaver AL, et al. Malignant melanoma in solid transplant recipients: Collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis. Arch Dermatol 2011; 147: 790-796.
17. Penn I., Malignant melanoma in organ allograft recipients. Transplantation 1996; 61: 274-278. (Pubitemid 26044543)
18. Jaro MA., Probabalistic linkage of large public health data files. Stat Med 1995; 14: 491-498.
19. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-3648. (Pubitemid 32786276)
20. Cleeves M, Gutierrez RG, Gould W, Marchenko YV., An introduction to survival analysis using Stata. 3rd ed. College Station: Stata Press, 2010.
21. Fine JP, Gray RJ., A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
22. Rabe-Hesketh SR, Skrondal A., Multilevel and longitudinal modeling using Stata. Volume II: Categorical responses, counts and survival. College Station: Stata Press, 2012.
23. Little RJ, Rubin DB., Statistical analysis with missing data. 2nd ed. Hoboken: Wiley-InterScience, 2002.
24. Carlin JB, Galati JC, Royston P., A new framework for managing and analyzing multiple imputed data in Stata. Stata Journal 2008; 8: 49-67.
25. Paulson KG, Iyer JG, Blom A, et al. Systemic immune suppression predicts diminished merkel cell carcinoma-specific survival independent of stage. J Invest Dermatol 2013; 133: 642-646.
26. Webster AC, Wong G, McDonald SP., Cancer report. In. Australia and New Zealand Dialysis and Transplant Registry Report 2009. Adelaide, South Australia: ANZDATA, 2010.
27. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9: S1-S155.
28. Han D, Zager JS, Shyr Y, et al. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. J Clin Oncol 2013; 31: 4387-4393.
29. Kaddu S, Smolle J, Zenahlik P, Hofmann-Wellenhof R, Kerl H., Melanoma with benign melanocytic naevus components: Reappraisal of clinicopathological features and prognosis. Melanoma Res 2002; 12: 271-278. (Pubitemid 34666818)
30. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. Wellington: Cancer Council Australia and Australian Cancer Network and New Zealand Guidelines Group, 2008.
31. Li SQ, Cass A, Cunningham J., Cause of death in patients with end-stage renal disease: Assessing concordance of death certificates with registry reports. Aust N Z J Public Health 2003; 27: 419-424. (Pubitemid 37038223)